- Free from Publisher F Tomai, B Reimers, L De Luca, AR Galassi, A … - Diabetes care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We designed a prospective, randomized study to
compare the efficacy in prevention of restenosis of SES and PES, both implanted
in the same diabetic patient with multiple de novo coronary artery lesions ... Cited by 12 - Related articles - BL Direct - All 8 versions
- ►oxfordjournals.org M Billinger, J Beutler, KR Taghetchian, A … - European Heart Journal, 2008 - Eur Soc Cardiology Methods and results: In the SIRTAX trial, 1012 patients were randomized to
treatment with SES (n = 503) or PES (n = 509). A stratified analysis of outcomes
was performed according to the presence or absence of diabetes. Baseline ... Cited by 19 - Related articles - BL Direct - All 7 versions
V Ferrero, L Favero, G Gioffr, F Prati, C … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS — We designed a prospective, randomized study to
compare the efficacy in prevention of restenosis of SES and PES, both implanted
in the same diabetic patient with multiple de novo coronary artery lesions ... Related articles
[CITATION] DESSERT Investigators. Comparison of effectiveness and safety of sirolimus-eluting stents …
- ►onlinejacc.org D Baumgart, V Klauss, F Baer, F Hartmann, H … - Journal of the American College of Cardiology, 2007 - Elsevier This study sought to analyze the effectiveness of drug-eluting stents in a
high-risk group of diabetic patients. Previously, this had been analyzed only in
substudies of larger trials or in clinical investigations enrolling a small ... Cited by 21 - Related articles - All 12 versions
G Stankovic, J Cosgrave, A Chieffo, I Iakovou, … - The American journal of cardiology, 2006 - Elsevier Randomized trials have shown that implantation of sirolimus-eluting stents
(SESs) and paclitaxel-eluting stents (PESs) reduce the incidence of major
adverse cardiac events (MACEs) compared with bare metal stents. We compared ... Cited by 25 - Related articles - All 14 versions
AN Buch, A Javaid, DH Steinberg, P Roy, TL … - The American Journal of Cardiology, 2008 - Elsevier Insulin-treated diabetic patients undergoing drug-eluting stent implantation are
prone to high rates of adverse cardiac events. The efficacy of the sirolimus-
(SES) and paclitaxel-eluting stent (PES) in this population was analyzed. ... Cited by 10 - Related articles - BL Direct - All 15 versions
G HELLIGE, S WINDECKER - Journal of Interventional Cardiology, 2009 - interscience.wiley.com Drug-eluting stents (DES) have been appraised as breakthrough technology owing
to their potent reduction of restenosis, an important nuisance in the quality of
life of affected patients, the rare cause of myocardial infarction, and the ... Related articles - All 2 versions
C Cola, S Brugaletta, VM Yuste, B Campos, DJ … - Vascular Health and Risk Management, 2009 - pubmedcentral.nih.gov Coronary stent thrombosis is a serious problem in the drug-eluting stent era.
Despite aggressive antiplatelet therapy during and after percutaneous coronary
intervention (PCI), the incidence of sub-acute stent thrombosis remains ... Related articles - All 6 versions
M Balducelli, P Ortolani, P Marzaroli, G … - Catheterization and Cardiovascular Interventions, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
